C4 Therapeutics Latest Filings
Ownership
02/27/2025
Form S-8 - Securities to be offered to employees in employee benefit plans
Interim
02/27/2025
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Event
02/27/2025
Form 8-K - Current report
Report Period: Q4' FY2024
Financial Results:
: revenue $5.18M, estimate $3.60M;
: EPS $-0.49, concensus $-0.37
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Show More Filings
